Harbor Capital Advisors Inc. Purchases 36,577 Shares of Oscar Health, Inc. (NYSE:OSCR)

Harbor Capital Advisors Inc. lifted its position in shares of Oscar Health, Inc. (NYSE:OSCR) by 39.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 128,167 shares of the company’s stock after purchasing an additional 36,577 shares during the period. Harbor Capital Advisors Inc.’s holdings in Oscar Health were worth $1,723,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in OSCR. Westfield Capital Management Co. LP acquired a new stake in shares of Oscar Health in the third quarter valued at about $27,452,000. JPMorgan Chase & Co. boosted its holdings in Oscar Health by 68.5% in the third quarter. JPMorgan Chase & Co. now owns 2,309,150 shares of the company’s stock valued at $48,977,000 after acquiring an additional 938,742 shares during the last quarter. Renaissance Technologies LLC increased its position in Oscar Health by 31.7% during the 2nd quarter. Renaissance Technologies LLC now owns 3,886,100 shares of the company’s stock valued at $61,478,000 after purchasing an additional 934,600 shares during the period. Point72 Asset Management L.P. bought a new position in Oscar Health during the 2nd quarter worth approximately $14,716,000. Finally, Soros Fund Management LLC bought a new position in Oscar Health during the 3rd quarter worth approximately $12,726,000. Institutional investors and hedge funds own 75.70% of the company’s stock.

Analyst Ratings Changes

A number of research firms have recently commented on OSCR. UBS Group began coverage on shares of Oscar Health in a research note on Monday, October 7th. They issued a “neutral” rating and a $23.00 price objective on the stock. Jefferies Financial Group began coverage on Oscar Health in a report on Tuesday, December 10th. They set an “underperform” rating and a $12.00 price target for the company. Finally, Bank of America downgraded Oscar Health from a “neutral” rating to an “underperform” rating and dropped their price objective for the company from $21.00 to $13.50 in a research note on Wednesday, November 6th. Two investment analysts have rated the stock with a sell rating, two have given a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $21.56.

Oscar Health Stock Performance

Shares of OSCR opened at $14.12 on Monday. The stock has a 50-day moving average of $15.10 and a 200-day moving average of $16.88. Oscar Health, Inc. has a one year low of $9.70 and a one year high of $23.79. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. The company has a market cap of $3.49 billion, a PE ratio of -235.29 and a beta of 1.70.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing the consensus estimate of ($0.20) by ($0.02). Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The firm had revenue of $2.42 billion for the quarter, compared to the consensus estimate of $2.33 billion. During the same quarter in the prior year, the firm earned ($0.29) EPS. The company’s revenue was up 68.3% compared to the same quarter last year. On average, equities research analysts predict that Oscar Health, Inc. will post -0.01 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, Vice Chairman Joshua Kushner acquired 358,619 shares of the stock in a transaction dated Wednesday, November 13th. The stock was purchased at an average cost of $13.74 per share, with a total value of $4,927,425.06. Following the completion of the purchase, the insider now directly owns 5,810,700 shares in the company, valued at $79,839,018. This trade represents a 6.58 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Victoria Baltrus sold 8,078 shares of Oscar Health stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total value of $146,050.24. Following the transaction, the chief accounting officer now directly owns 146,036 shares in the company, valued at approximately $2,640,330.88. The trade was a 5.24 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have acquired 1,055,478 shares of company stock worth $14,432,852 and have sold 103,610 shares worth $1,847,519. Corporate insiders own 25.11% of the company’s stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.